Fisher Wallace Laboratories cover feature

Fisher Wallace Laboratories

Medical Devices for Mood and Sleep
$47,050 Raised
Ends January 7th
32 Investors
Drug therapy provides low to modest efficacy with high side effect rate and high cost
Antidepressants, anti-anxiety and sleep medications all have a high rate of side effects, and even in generic form can be very expensive - and the many doctor visits needed to manage medication are also costly. Behavioral therapy (psychotherapy or CBT) does not cause serious side effects but is expensive to administer and requires a very high level of patient engagement....
Learn more about this company

Other popular startups

Get email updates for the latest investment opportunities